Strengthening the evidence base for decisions on public health and social measures
Delia Enría(Administración Nacional de Laboratorios e Institutos de Salud), Nahoko Shindo(World Health Organization), Trygve Ottersen(Norwegian Institute of Public Health), Victoria Haldane(World Health Organization), Chikwe Ihekweazu(Nigeria Centre for Disease Control), Margaux Mathis(World Health Organization), Jaya Lamichhane(Kathmandu University), Sylvie Briand(World Health Organization), Atle Fretheim(Norwegian Institute of Public Health), Kumnuan Ungchusak(Ministry of Public Health), Zijian Feng(Chinese Center For Disease Control and Prevention), Tim Nguyen(Novartis (United States)), Anne Schuchat(National Center for Injury Prevention and Control), Ramona Ludolph(World Health Organization)
Cited by 18
Related Papers
COVID-19: what is next for public health?
|The Lancet|2020|1.2k
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
|New England Journal of Medicine|2010|1.1k
Increasing Prevalence of Multidrug-Resistant<i>Streptococcus pneumoniae</i>in the United States
|New England Journal of Medicine|2000|899
Evaluation of diagnostic tests: dengue
|Nature Reviews Microbiology|2010|588
Middle East Respiratory Syndrome
|New England Journal of Medicine|2017|511